BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

Import this data to Google Sheets with:

=jivedata("BFNH","financials")

Full statements spill as a table. For one cell: =jivedata("BFNH","Revenue") or =jivedata("BFNH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

BIOFORCE NANOSCIENCES HOLDINGS, INC.

BFNH • CIK 0001310488

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	—	$-489.951	$-613.776
Net Income (Loss) Attributable to Parent	$-471.953	$-490.437	$-1,291.951	$-98.249
Weighted Average Number of Shares Outstanding, Basic	29,271,755	29,271,755	33,207,371	33,852,490
Compensation Expense, Excluding Cost of Good and Service Sold	$423	$423	$423	$461
General and Administrative Expense	$48.953	$67.437	$66.951	$152.776
Operating Expenses	$471.953	$490.437	$489.951	$613.776

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$0.638	$0.862	$0.786	$0.307
Liabilities, Current	$1,819.868	$2,302.454	$619.329	$84.767
Common Stock, Value, Issued	$29.272	$29.272	$33.522	$33.549
Additional Paid in Capital, Common Stock	$158,781.227	$158,789.302	$161,760.052	$162,061.305
Retained Earnings (Accumulated Deficit)	$-160,629.729	$-161,120.166	$-162,412.117	$-162,275.846
Stockholders' Equity Attributable to Parent	$-1,819.23	$-2,301.592	$-618.543	$2,303.308
Accounts Payable and Accrued Liabilities, Current	$2.649	$8.836	$11.836	$12.284
Accrued Salaries	$1,596.517	$2,019.517	$506.203	$21.75
Preferred Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares Authorized	900,000,000	900,000,000	900,000,000	900,000,000
Common Stock, Shares, Issued	29,271,755	29,271,755	33,521,755	33,549,005

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-471.953	$-490.437	$-1,291.951	$-98.249
Net Cash Provided by (Used in) Operating Activities	$-46.702	$-61.25	$-65.15	$-41.934
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-0.096	$0.224	$-0.076	$-0.598
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$0.638	$0.862	$0.786	$-6.666
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$2.251	$6.187	$3	$4.712
Increase (Decrease) in Accrued Salaries	$423	$423	$421.801	$299.551
Proceeds from Related Party Debt	$46.606	$53.399	$65.074	$65.074
Net Cash Provided by (Used in) Financing Activities	$46.606	$61.474	$65.074	$41.336

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("BFNH","financials")

Full statements spill as a table. For one cell: =jivedata("BFNH","Revenue") or =jivedata("BFNH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.